More on COGT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $32.62 |
|
|||
| Open | $32.62 | ||||
| 52 Wk High | $5.57 | ||||
| 52 Wk Low | $2.90 | ||||
| Day High | $32.62 | ||||
| Day Low | $32.62 | ||||
| P/E | 148.27 | ||||
| EPS | $0.22 | ||||
| Volume | 2 | ||||
- Form 4 Cogent Biosciences, Inc. For: Jun 09 Filed by: Harwin Peter Evan
- Form 4 Cogent Biosciences, Inc. For: Jun 09 Filed by: CAIN CHRISTOPHER W.
- Form 4 Cogent Biosciences, Inc. For: Jun 09 Filed by: Ferrante Karen Jean
- Form 4 Cogent Biosciences, Inc. For: Jun 09 Filed by: Morris Arlene
- Form 4 Cogent Biosciences, Inc. For: Jun 09 Filed by: Shegog Todd
- Form 4 Cogent Biosciences, Inc. For: Jun 09 Filed by: Ros Matthew
- Form 8-K Cogent Biosciences, Inc. For: Jun 09
- Cogent (COGT) Reiterated at Buy by Stifel After ASCO Presentation on Bezuclastinib
- H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
- Cogent Biosciences reports positive Phase 3 trial data for GIST treatment
Entities mentioned with COGT
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- S3 | View Related Stories »
- Show More...
